SCHEMBL8201409

SCHEMBL8201409

CCOC(=O)Cn1cnc2c(c1=O)CC(C#N)(c1ccc(OC)c3oc4ccccc4c13)CC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.43
RXFP1 Q9HBX9 2/20 0.43
KMT2A Q03164 2/20 0.41
HSD17B10 Q99714 1/20 0.40
MAPT P10636 5/20 0.40
ALDH1A1 P00352 4/20 0.39
NPSR1 Q6W5P4 3/20 0.39
TSHR P16473 2/20 0.39
HPGD P15428 2/20 0.39
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
RAB9A P51151 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4017282 0.92 HDAC6 (0.44) POLBRXFP1KMT2AHSD17B10MAPT
SCHEMBL8212482 0.87 POLB (0.36) POLBRXFP1KMT2AHSD17B10MAPT
SCHEMBL12316291 0.87 POLB (0.41) POLBRXFP1KMT2AHSD17B10MAPT
SCHEMBL4016542 0.84 CYP19A1 (0.37) KMT2AHSD17B10MAPTALDH1A1RAB9A
SCHEMBL14856886 0.83 HSD17B10 (0.34) RXFP1KMT2AHSD17B10MAPTALDH1A1
SCHEMBL4513853 0.83 ALDH1A1 (0.43) KMT2AHSD17B10MAPTALDH1A1CYP1A2
SCHEMBL12342055 0.82 KDM4E (0.34) POLBRXFP1KMT2AHSD17B10MAPT
SCHEMBL4537205 0.81 NPC1 (0.36) POLBKMT2AHSD17B10MAPTALDH1A1
SCHEMBL4519628 0.78 ALDH1A1 (0.36) KMT2AMAPTALDH1A1CYP1A2CYP2C9
SCHEMBL12316292 0.78 HDAC6 (0.44) POLBRXFP1KMT2AHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263648-B2 Diebenzofuran derivatives as inhibitors of PDE-4 and PDE-10 Mylan Laboratories Ltd. (IN) 2012-09-11 US disclosed
US-20090281131-A1 DIEBENZOFURAN DERIVATIVES AS INHIBITORS OF PDE-4 AND PDE-10 MYLAN LABORATORIES LIMITED (IN) 2009-11-12 US disclosed
WO-2008032171-A1 DIBENZOFURAN DERIVATIVES AS INHIBITORS OF PDE-4 AND PDE-10 MATRIX LABORATORIES LTD. (DE) 2008-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281131-A1 DIEBENZOFURAN DERIVATIVES AS INHIBITORS OF PDE-4 AND PDE-10 PDE4A, PDE4B, PDE12 POLB 1968/4885RXFP1 1097/4885KMT2A 3065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.